Literature DB >> 1316435

In-vitro and in-vivo wear profile of composite resins.

N Satou1, A M Khan, K Satou, J Satou, H Shintani, K Wakasa, M Yamaki.   

Abstract

The aim of this study was to evaluate in-vitro wear by two types of slurry of 10 commercial composite resin materials (seven hybrid and three microfilled composites). There was great variation in the in-vitro wear pattern by two types of slurry. The wear rate of microfilled composites was greater than that of hybrid composites, and a negative correlation was observed between wear rate and Knoop hardness values among all materials when hydroxyapatite slurry was used. In contrast, the wear rate of hybrid composites was greater than that of microfilled composites when abraded by green carborundum slurry. These abraded surfaces were compared with SEM micrographs of in-vivo composites surface after 4 years of service. The profile of in-vivo wear surfaces was found to be similar to that of in-vitro wear surfaces abraded with hydroxyapatite slurry.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316435     DOI: 10.1111/j.1365-2842.1992.tb01588.x

Source DB:  PubMed          Journal:  J Oral Rehabil        ISSN: 0305-182X            Impact factor:   3.837


  3 in total

1.  [Evaluation of wear property of Giomer and universal composite in vivo].

Authors:  H L Mu; F C Tian; X Y Wang; X J Gao
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-12-21

2.  Characterization of third-body media particles and their effect on in vitro composite wear.

Authors:  Nathaniel C Lawson; Deniz Cakir; Preston Beck; Mark S Litaker; John O Burgess
Journal:  Dent Mater       Date:  2012-05-10       Impact factor: 5.304

3.  Three-year randomised clinical trial to evaluate the clinical performance, quantitative and qualitative wear patterns of hybrid composite restorations.

Authors:  Senthamaraiselvi Palaniappan; Liesbeth Elsen; Inge Lijnen; Marleen Peumans; Bart Van Meerbeek; Paul Lambrechts
Journal:  Clin Oral Investig       Date:  2009-08-08       Impact factor: 3.573

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.